GSK and Vir Biotechnology announce USA government agreements to purchase sotrovimab, a COVID-19 treatment.
GSK and Vir Biotechnology announced US govt contracts totalling approximately $1 billion USD to purchase sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19...
|